Compare Dishman Pharma with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs J.B.CHEMICALS - Comparison Results

DISHMAN PHARMA     Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA J.B.CHEMICALS DISHMAN PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 25.1 45.3 55.3% View Chart
P/BV x 3.3 8.4 39.7% View Chart
Dividend Yield % 0.7 0.1 476.3%  

Financials

 DISHMAN PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
J.B.CHEMICALS
Mar-18
DISHMAN PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs374363 103.1%   
Low Rs129255 50.5%   
Sales per share (Unadj.) Rs197.8169.1 116.9%  
Earnings per share (Unadj.) Rs21.216.6 127.8%  
Cash flow per share (Unadj.) Rs34.723.4 148.3%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.80.6 122.8%  
Book value per share (Unadj.) Rs179.9172.5 104.3%  
Shares outstanding (eoy) m80.6983.57 96.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x1.31.8 69.6%   
Avg P/E ratio x11.918.6 63.7%  
P/CF ratio (eoy) x7.213.2 54.9%  
Price / Book Value ratio x1.41.8 78.1%  
Dividend payout %9.412.0 78.3%   
Avg Mkt Cap Rs m20,30625,827 78.6%   
No. of employees `0000.83.8 22.0%   
Total wages/salary Rs m5,3552,511 213.3%   
Avg. sales/employee Rs Th19,252.73,747.4 513.8%   
Avg. wages/employee Rs Th6,459.5665.7 970.3%   
Avg. net profit/employee Rs Th2,064.1367.8 561.2%   
INCOME DATA
Net Sales Rs m15,96114,135 112.9%  
Other income Rs m265366 72.6%   
Total revenues Rs m16,22614,501 111.9%   
Gross profit Rs m4,1032,178 188.4%  
Depreciation Rs m1,091570 191.4%   
Interest Rs m94435 2,706.0%   
Profit before tax Rs m2,3341,940 120.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624552 112.9%   
Profit after tax Rs m1,7111,387 123.3%  
Gross profit margin %25.715.4 166.8%  
Effective tax rate %26.728.5 93.8%   
Net profit margin %10.79.8 109.2%  
BALANCE SHEET DATA
Current assets Rs m11,01810,470 105.2%   
Current liabilities Rs m9,5172,749 346.2%   
Net working cap to sales %9.454.6 17.2%  
Current ratio x1.23.8 30.4%  
Inventory Days Days11055 200.2%  
Debtors Days Days3578 44.9%  
Net fixed assets Rs m16,3045,811 280.6%   
Share capital Rs m161167 96.6%   
"Free" reserves Rs m12,90714,248 90.6%   
Net worth Rs m14,51614,416 100.7%   
Long term debt Rs m4,1890-   
Total assets Rs m29,80517,649 168.9%  
Interest coverage x3.556.6 6.1%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.50.8 66.9%   
Return on assets %8.98.1 110.6%  
Return on equity %11.89.6 122.5%  
Return on capital %17.513.7 128.0%  
Exports to sales %24.80-   
Imports to sales %3.70-   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m596NA-   
Fx inflow Rs m4,9526,164 80.3%   
Fx outflow Rs m6971,334 52.2%   
Net fx Rs m4,2554,829 88.1%   
CASH FLOW
From Operations Rs m2,7861,231 226.4%  
From Investments Rs m-1,529-208 734.7%  
From Financial Activity Rs m-941-595 158.1%  
Net Cashflow Rs m316427 74.1%  

Share Holding

Indian Promoters % 61.4 55.4 110.8%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 3.7 3.4 109.1%  
FIIs % 12.7 3.9 325.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.1 37.0 59.7%  
Shareholders   46,261 30,437 152.0%  
Pledged promoter(s) holding % 35.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   ALEMBIC PHARMA  BIOCON   FULFORD INDIA  JUBILANT PHARMOVA   DIVIS LABORATORIES  

Compare DISHMAN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; JSW Steel and Hindalco Among Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA - SHASUN PHARMA COMPARISON

COMPARE DISHMAN PHARMA WITH

MARKET STATS